Dual-targeted molecular probes for cancer imaging

Current Pharmaceutical Biotechnology

Volumn 11, Issue 6, 2010, Pages 610-619

  Liu, Zhaofei ^a,b   Wang, Fan ^a,b  

^a PEKING UNIVERSITY   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Dual targeted; Molecular imaging; Peptide heterodimer; Receptor; Tumor

Indexed keywords

APTAMER; BISPECIFIC ANTIBODY; BOMBESIN; CARBON NANOTUBE; CHOLECYSTOKININ RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; FLUORODEOXYGLUCOSE F 18; GALLIUM 68; GASTRIN RELEASING PEPTIDE RECEPTOR; GLUCAGON LIKE PEPTIDE 1; GOLD NANOPARTICLE; INTEGRIN RECEPTOR; IODINE 123; IODINE 131; NANOPARTICLE; NEUROPEPTIDE Y RECEPTOR; NEUROTENSIN RECEPTOR; PENTETREOTIDE IN 111; QUANTUM DOT; RHENIUM 188; SOMATOSTATIN RECEPTOR; SUPERPARAMAGNETIC IRON OXIDE; TECHNETIUM 99M; VASCULOTROPIN INHIBITOR; YTTRIUM 90; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

BREAST CANCER; CANCER DIAGNOSIS; CELL ACTIVATION; DIAGNOSTIC IMAGING; ECHOGRAPHY; GLIOMA; HUMAN; LUNG SMALL CELL CANCER; MELANOMA; MOLECULAR PROBE; NEOPLASM; NEUROENDOCRINE TUMOR; NONHUMAN; OVARY CANCER; POSITRON EMISSION TOMOGRAPHY; PROTEIN TARGETING; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUBRETINAL NEOVASCULARIZATION; TUMOR; TUMOR CELL DESTRUCTION; ARTICLE; GENETIC PROCEDURES; IMAGE ENHANCEMENT; METHODOLOGY; MOLECULAR IMAGING; SCINTISCANNING;

HUMANS; IMAGE ENHANCEMENT; MOLECULAR IMAGING; MOLECULAR PROBE TECHNIQUES; MOLECULAR PROBES; NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS;

EID: 79952115394     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920110792246546     Document Type: Review

References (65)

1. Weissleder, R.; Mahmood, U. Molecular imaging. Radiology. 2001, 219. 316-333.
2. Massoud, T.F.; Gambhir, S.S. Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev. 2003, 17. 545-580.
3. Cai, W.; Niu, G.; Chen, X. Imaging of integrins as biomarkers for tumor angiogenesis. Curr. Pharm. Des. 2008, 14. 2943-2973.
4. Cai, W.; Chen, X. Multimodality molecular imaging of tumor angiogenesis. J. Nucl. Med. 2008, 49. 113S-128S.
5. Mankoff, D.A.; Link, J.M.; Linden, H.M.; Sundararajan, L.; Krohn, K.A. Tumor receptor imaging. J. Nucl. Med. 2008, 49. 149S-163S.
6. Reubi, J.C.; Maecke, H.R. Peptide-based probes for cancer imaging. J. Nucl. Med. 2008, 49. 1735-1738.
7. Reubi, J.C.; Waser, B. Concomitant expression of several peptide receptors in neuroendocrine tumours: molecular basis for in vivo multireceptor tumour targeting. Eur. J. Nucl. Med. Mol. Imaging. 2003, 30. 781-793.
8. Reubi, J.C. Peptide receptors as molecular targets for cancer diagnosis and therapy. Endocr. Rev. 2003, 24. 389-427.
9. de Jong, M.; Breeman, W.A.; Kwekkeboom, D.J.; Valkema, R.; Krenning, E.P. Tumor imaging and therapy using radiolabeled somatostatin analogues. Acc. Chem. Res. 2009, 42. 873-880.
10. Kwekkeboom, D.J.; Krenning, E.P. Somatostatin receptor imaging. Semin. Nucl. Med. 2002, 32. 84-91.
11. Ananias, H.J.; de Jong, I.J.; Dierckx, R.A.; van de Wiele, C.; Helfrich, W.; Elsinga, P.H. Nuclear imaging of prostate cancer with gastrin-releasing-peptide-receptor targeted radiopharmaceuticals. Curr. Pharm. Des. 2008, 14. 3033-3047.
12. Reubi, J.C. Targeting CCK receptors in human cancers. Curr. Top. Med. Chem. 2007, 7. 1239-1242.
13. Mishani, E.; Abourbeh, G.; Eiblmaier, M.; Anderson, C.J. Imaging of EGFR and EGFR tyrosine kinase overexpression in tumors by nuclear medicine modalities. Curr. Pharm. Des. 2008, 14. 2983-2998.
14. Pelosi, G.; Volante, M.; Papotti, M.; Sonzogni, A.; Masullo, M.; Viale, G. Peptide receptors in neuroendocrine tumors of the lung as potential tools for radionuclide diagnosis and therapy. Q. J. Nucl. Med. Mol. Imaging. 2006, 50. 272-287.
15. Zaccaro, L.; Del Gatto, A.; Pedone, C.; Saviano, M. Peptides for tumour therapy and diagnosis: current status and future directions. Curr. Med. Chem. 2009, 16. 780-795.
16. Mezo, G.; Manea, M. Receptor-mediated tumor targeting based on peptide hormones. Expert Opin. Drug Deliv. 2010, 7. 79-96.
17. Patel, Y.C. Somatostatin and its receptor family. Front Neuroendocrinol. 1999, 20. 157-198.
18. Hynes, R.O. Integrins: bidirectional, allosteric signaling machines. Cell. 2002, 110. 673-687.
19. Cai, W.; Chen, X. Anti-angiogenic cancer therapy based on integrin alphavbeta3 antagonism. Anticancer Agents Med. Chem. 2006, 6. 407-428.
20. 3-targeted cancer therapy. Drug Develop. Res. 2008, 69. 329-339.
21. 3expression. Cancer Metastasis Rev. 2008, 27. 631-644.
22. Anastasi, A.; Erspamer, V.; Bucci, M. Isolation and structure of bombesin and alytesin, 2 analogous active peptides from the skin of the European amphibians Bombina and Alytes. Experientia. 1971, 27. 166-167.
23. Smith, C.J.; Volkert, W.A.; Hoffman, T.J. Gastrin releasing peptide (GRP) receptor targeted radiopharmaceuticals: a concise update. Nucl. Med. Biol. 2003, 30. 861-868.
24. Smith, C.J.; Volkert, W.A.; Hoffman, T.J. Radiolabeled peptide conjugates for targeting of the bombesin receptor superfamily subtypes. Nucl. Med. Biol. 2005, 32. 733-740.
25. Van de Wiele, C.; Phonteyne, P.; Pauwels, P.; Goethals, I.; Van den Broecke, R.; Cocquyt, V.; Dierckx, R.A. Gastrin-releasing peptide receptor imaging in human breast carcinoma versus immunohistochemistry. J. Nucl. Med. 2008, 49. 260-264.
26. 99mTc-EDDA/HYNIC-[Lys3]-bombesin: biokinetics and dosimetry in women. Nucl. Med. Commun. 2008, 29. 741-747.
27. 18F-FDG. J. Nucl. Med. 2007, 48. 1245-1250.
28. 68Ga-labeled NOTA-RGDBBN peptide for dual integrin and GRPR-targeted tumor imaging. Eur. J. Nucl. Med. Mol. Imaging. 2009, 36. 1483-1494.
29. Lee, S.; Xie, J.; Chen, X. Peptide-based probes for targeted molecular imaging. Biochemistry. 2010, 49. 1364-1376.
30. 18F-FB-PEG3-Glu-RGD-BBN. J. Med. Chem. 2009, 52. 425-432.
31. Bernard, B.; Capello, A.; van Hagen, M.; Breeman, W.; Srinivasan, A.; Schmidt, M.; Erion, J.; van Gameren, A.; Krenning, E.; de Jong, M. Radiolabeled RGD-DTPA-Tyr3-octreotate for receptortargeted radionuclide therapy. Cancer Biother. Radiopharm. 2004, 19. 173-180.
32. Yang, J.; Guo, H.; Gallazzi, F.; Berwick, M.; Padilla, R.S.; Miao, Y. Evaluation of a novel Arg-Gly-Asp-conjugated alphamelanocyte stimulating hormone hybrid peptide for potential melanoma therapy. Bioconjug. Chem. 2009, 20, 1634-1642.
33. Capello, A.; Krenning, E.P.; Bernard, B.F.; Breeman, W.A.; van Hagen, M.P.; de Jong, M. Increased cell death after therapy with an Arg-Gly-Asp-linked somatostatin analog. J. Nucl. Med. 2004, 45. 1716-1720.
34. Capello, A.; Krenning, E.P.; Bernard, B.F.; Breeman, W.A.; Erion, J.L.; de Jong, M. Anticancer activity of targeted proapoptotic peptides. J. Nucl. Med. 2006, 47. 122-129.
35. Vagner, J.; Xu, L.; Handl, H.L.; Josan, J.S.; Morse, D.L.; Mash, E.A.; Gillies, R.J.; Hruby, V.J. Heterobivalent ligands crosslink multiple cell-surface receptors: the human melanocortin-4 and delta-opioid receptors. Angew. Chem., Int. Ed. Engl. 2008, 47. 1685-1688.
36. Josan, J.S.; Vagner, J.; Handl, H.L.; Sankaranarayanan, R.; Gillies, R.J.; Hruby, V.J. Solid-phase synthesis of heterobivalent ligands targeted to melanocortin and cholecystokinin receptors. Int. J. Pept. Res. Ther. 2008, 14. 293-300.
37. Monguchi, Y.; Vagner, J.; Handl, H.L.; Jana, U.; Begay, L.J.; Hruby, V.J.; Gillies, R.J.; Mash, E.A. Design, synthesis, and validation of rigid linkers for bioactive peptides. Tetrahedron Lett. 2005, 46. 7589-7592.
38. Vagner, J.; Handl, H.L.; Gillies, R.J.; Hruby, V.J. Novel targeting strategy based on multimeric ligands for drug delivery and molecular imaging: homooligomers of alpha-MSH. Bioorg. Med. Chem. Lett. 2004, 14. 211-215.
39. Handl, H.L.; Vagner, J.; Han, H.; Mash, E.; Hruby, V.J.; Gillies, R.J. Hitting multiple targets with multimeric ligands. Expert Opin. Ther. Targets. 2004, 8. 565-586.
40. Buckley, C.D.; Pilling, D.; Henriquez, N.V.; Parsonage, G.; Threlfall, K.; Scheel-Toellner, D.; Simmons, D.L.; Akbar, A.N.; Lord, J.M.; Salmon, M. RGD peptides induce apoptosis by direct caspase-3 activation. Nature. 1999, 397. 534-539.
41. 18F-labeled BBNRGD heterodimer for prostate cancer imaging. J. Nucl. Med. 2008, 49. 453-461.
42. Tinkov, S.; Bekeredjian, R.; Winter, G.; Coester, C. Microbubbles as ultrasound triggered drug carriers. J. Pharm. Sci. 2009, 98. 1935-1961.
43. Patel, R.M. Microbubble: a potential ultrasound tool in molecular imaging. Curr. Pharm. Biotechnol. 2008, 9. 406-410.
44. Weller, G.E.; Villanueva, F.S.; Tom, E.M.; Wagner, W.R. Targeted ultrasound contrast agents: in vitro assessment of endothelial dysfunction and multi-targeting to ICAM-1 and sialyl Lewisx. Biotechnol. Bioeng. 2005, 92. 780-788.
45. Cai, W.; Chen, X. Nanoplatforms for targeted molecular imaging in living subjects. Small. 2007, 3. 1840-1854.
46. Singh, S.R.; Grossniklaus, H.E.; Kang, S.J.; Edelhauser, H.F.; Ambati, B.K.; Kompella, U.B. Intravenous transferrin, RGD peptide and dual-targeted nanoparticles enhance anti-VEGF intraceptor gene delivery to laser-induced CNV. Gene Ther. 2009, 16. 645-659.
47. Reff, M.E.; Heard, C. A review of modifications to recombinant antibodies: attempt to increase efficacy in oncology applications. Crit. Rev. Oncol. Hematol. 2001, 40. 25-35.
48. Muller, D.; Kontermann, R.E. Bispecific antibodies for cancer immunotherapy: Current perspectives. BioDrugs. 2010, 24. 89-98.
49. Chames, P.; Baty, D. Bispecific antibodies for cancer therapy. Curr. Opin. Drug Discov. Devel. 2009, 12. 276-283.
50. Goldenberg, D.M. Targeted therapy of cancer with radiolabeled antibodies. J. Nucl. Med. 2002, 43. 693-713.
51. Lu, D.; Zhang, H.; Koo, H.; Tonra, J.; Balderes, P.; Prewett, M.; Corcoran, E.; Mangalampalli, V.; Bassi, R.; Anselma, D.; Patel, D.; Kang, X.; Ludwig, D.L.; Hicklin, D.J.; Bohlen, P.; Witte, L.; Zhu, Z. A fully human recombinant IgG-like bispecific antibody to both the epidermal growth factor receptor and the insulin-like growth factor receptor for enhanced antitumor activity. J. Biol. Chem. 2005, 280. 19665-19672.
52. Lu, D.; Zhang, H.; Ludwig, D.; Persaud, A.; Jimenez, X.; Burtrum, D.; Balderes, P.; Liu, M.; Bohlen, P.; Witte, L.; Zhu, Z. Simultaneous blockade of both the epidermal growth factor receptor and the insulin-like growth factor receptor signaling pathways in cancer cells with a fully human recombinant bispecific antibody. J. Biol. Chem. 2004, 279. 2856-2865.
53. Bostrom, J.; Yu, S.F.; Kan, D.; Appleton, B.A.; Lee, C.V.; Billeci, K.; Man, W.; Peale, F.; Ross, S.; Wiesmann, C.; Fuh, G. Variants of the antibody herceptin that interact with HER2 and VEGF at the antigen binding site. Science. 2009, 323. 1610-1614.
54. Perkins, A.C.; Missailidis, S. Radiolabelled aptamers for tumour imaging and therapy. Q. J. Nucl. Med. Mol. Imaging. 2007, 51. 292-296.
55. Hicke, B.J.; Stephens, A.W.; Gould, T.; Chang, Y.F.; Lynott, C.K.; Heil, J.; Borkowski, S.; Hilger, C.S.; Cook, G.; Warren, S.; Schmidt, P.G. Tumor targeting by an aptamer. J. Nucl. Med. 2006, 47. 668-678.
56. Di Giusto, D.A.; King, G.C. Construction, stability, and activity of multivalent circular anticoagulant aptamers. J. Biol. Chem. 2004, 279. 46483-46489.
57. Borbas, K.E.; Ferreira, C.S.; Perkins, A.; Bruce, J.I.; Missailidis, S. Design and synthesis of mono-and multimeric targeted radiopharmaceuticals based on novel cyclen ligands coupled to anti-MUC1 aptamers for the diagnostic imaging and targeted radiotherapy of cancer. Bioconjug. Chem. 2007, 18. 1205-1212.
58. 3in prostate cancer progression. Neoplasia. 2002, 4. 191-194.
59. 64Cu-labeled RGD-bombesin heterodimer. J. Nucl. Med. 2009, 50. 1168-1177.
60. 68Ga labeled RGD-bombesin heterodimeric peptides for PET imaging of breast cancer. Bioconjug. Chem. 2009, 20. 1016-1025.
61. Willmann, J.K.; Lutz, A.M.; Paulmurugan, R.; Patel, M.R.; Chu, P.; Rosenberg, J.; Gambhir, S.S. Dual-targeted contrast agent for US assessment of tumor angiogenesis in vivo. Radiology. 2008, 248. 936-944.
62. Korpanty, G.; Grayburn, P.A.; Shohet, R.V.; Brekken, R.A. Targeting vascular endothelium with avidin microbubbles. Ultrasound Med. Biol. 2005, 31. 1279-1283.
63. Robertson, R.; Germanos, M.S.; Li, C.; Mitchell, G.S.; Cherry, S.R.; Silva, M.D. Optical imaging of Cerenkov light generation from positron-emitting radiotracers. Phys. Med. Biol. 2009, 54. N355-365.
64. Spinelli, A.E.; D'Ambrosio, D.; Calderan, L.; Marengo, M.; Sbarbati, A.; Boschi, F. Cerenkov radiation allows in vivo optical imaging of positron emitting radiotracers. Phys. Med. Biol. 2010, 55. 483-495.
65. Liu, H.; Ren, G.; Miao, Z.; Zhang, X.; Tang, X.; Han, P.; Gambhir, S.S.; Cheng, Z. Molecular optical imaging with radioactive probes. PLoS One. 2010, 5. e9470.